| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 20,000 | 15 Jun 2022 | Direct | ||
| Aura Biosciences, Inc. | Director | Stock Option (Right to Buy) | 16,000 | 07 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:56 |
| AURA | Aura Biosciences, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 17:09 |
| /report/000110465922072185-parekh-rajesh-b-2022-06-15 | Eloxx Pharmaceuticals, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 08:27 |
| AURA | Aura Biosciences, Inc. | 28 Oct 2021 | 1 | $0 | 4 | Director | 29 Oct 2021, 19:23 |
| AURA | Aura Biosciences, Inc. | 28 Oct 2021 | 0 | $0 | 3 | Director | 28 Oct 2021, 20:27 |
| /report/000141588921002615-parekh-rajesh-b-2021-05-19 | Eloxx Pharmaceuticals, Inc. | 19 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 16:11 |
| /report/000110465921067516-parekh-rajesh-b-2021-05-13 | Eloxx Pharmaceuticals, Inc. | 13 May 2021 | 2 | +$3,329,999 | 4 | Director | 17 May 2021, 09:22 |